● 2007 Schedule for ages 0-6 year
● 2007 Catch-up Schedule pdf
● 2007 Schedules PDF (adobe acrobat)

● Changes from 2006 schedule

• Administer at age 11–12 years for those who have completed the recommended childhood DTP/DTaP vaccination series and have not received a tetanus and diphtheria toxoids vaccine (Td) booster dose.
• Adolescents aged 13–18 years who missed the 11–12 year Td/Tdap booster dose should also receive a single dose of Tdap if they have completed the recommended childhood DTP/DTaP vaccination series.

2. Human papillomavirus vaccine (HPV). (Minimum age: 9 years)

• Administer the first dose of the HPV vaccine series to females at age 11–12 years.
• Administer the second dose 2 months after the first dose and the third dose 6 months after the first dose.
• Administer the HPV vaccine series to females at age 13–18 years if not previously vaccinated.
•  

3. Meningococcal vaccine. (Minimum age: 11 years for meningococcal conjugate vaccine [MCV4]; 2 years for meningococcal polysaccharide vaccine [MPSV4])

• Administer MCV4 at age 11–12 years and to previously unvaccinated adolescents at high school entry (at approximately age 15 years).
• Administer MCV4 to previously unvaccinated college freshmen living in dormitories; MPSV4 is an acceptable alternative.
• Vaccination against invasive meningococcal disease is recommended for children and adolescents aged >2 years with terminal complement deficiencies or anatomic or functional asplenia and certain other high-risk groups. See MMWR 2005;54(No. RR-7):1–21. Use MPSV4 for children aged 2–10 years and MCV4 or MPSV4 for older children.

4. Pneumococcal polysaccharide vaccine (PPV). (Minimum age: 2 years)

• Administer for certain high-risk groups. See MMWR 1997;46(No. RR-8):1–24, and MMWR 2000;49(No. RR-9):1–35.

5. Influenza vaccine. (Minimum age: 6 months for trivalent inactivated influenza vaccine [TIV]; 5 years for live, attenuated influenza vaccine [LAIV])

• Influenza vaccine is recommended annually for persons with certain risk factors, health-care workers, and other persons (including household members) in close contact with persons in groups at high risk. See MMWR 2006;55 (No. RR-10):1–41.
• For healthy persons aged 5–49 years, LAIV may be used as an alternative to TIV.
• Children aged <9 years who are receiving influenza vaccine for the first time should receive 2 doses (separated by >4 weeks for TIV and >6 weeks for LAIV).

6. Hepatitis A vaccine (HepA). (Minimum age: 12 months)

• The 2 doses in the series should be administered at least 6 months apart.
• HepA is recommended for certain other groups of children, including in areas where vaccination programs target older children. See MMWR 2006;55 (No. RR-7):1–23.

7. Hepatitis B vaccine (HepB). (Minimum age: birth)

• Administer the 3-dose series to those who were not previously vaccinated.
• A 2-dose series of Recombivax HB® is licensed for children aged 11–15 years.

8. Inactivated poliovirus vaccine (IPV). (Minimum age: 6 weeks)

• For children who received an all-IPV or all-oral poliovirus (OPV) series, a fourth dose is not necessary if the third dose was administered at age >4 years.
• If both OPV and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child’s current age.

9. Measles, mumps, and rubella vaccine (MMR). (Minimum age: 12 months)

• If not previously vaccinated, administer 2 doses of MMR during any visit, with >4 weeks between the doses.

10. Varicella vaccine. (Minimum age: 12 months)

• Administer 2 doses of varicella vaccine to persons without evidence of immunity.
• Administer 2 doses of varicella vaccine to persons aged <13 years at least 3 months apart. Do not repeat the second dose, if administered >28 days after the first dose.
• Administer 2 doses of varicella vaccine to persons aged >13 years at least 4 weeks apart.

• According to the updated recommendations for varicella vaccine, the first dose should be given at age 12 to 15 months, and a newly recommended second dose should be given at age 4 to 6 years.
• The new human papillomavirus (HPV) vaccine should be given in a 3-dose schedule, with the second and third doses given 2 and 6 months after the first dose. Girls aged 11 to 12 years should be routinely vaccinated with HPV vaccine, but this vaccination series can be started in girls as young as age 9 years. A catch-up vaccination is recommended for females aged 13 to 26 years who have not been vaccinated previously or who have not completed the full vaccine series.
• The new guidelines divide the recommendations into 2 schedules: 1 for children aged 0 to 6 years, and another for persons aged 7 to 18 years. Purple bars indicate special populations, and bold, capitalized fonts in the title highlight the 11- to 12-year evaluation. The catch-up immunization schedule incorporates the rotavirus, HPV, and varicella vaccines.

This page was last updated on January 23, 2008